Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Ipca Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524494NSE Symbol: IPCALABP/E(TTM):41.11
ISIN Demat:INE571A01038Div & Yield %:0.25EPS(TTM):38.18
Book Value(Rs):291.9817605Market Cap ( Cr.):39820.15Face Value(Rs):1
    Change Company 
Date Headline
08-Jan-26 Ipca Laboratories Ltd spurts 2.08%, rises for fifth straight session
06-Jan-26 Ipca Laboratories Ltd up for third consecutive session
18-Dec-25 Ipca Laboratories Ltd slips for fifth straight session
13-Nov-25 Ipca Laboratories consolidated net profit rises 23.13% in the September 2025 quarter
06-Nov-25 Ipca Laboratories Ltd - IPCA Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates
18-Oct-25 Ipca Laboratories to announce Quarterly Result
17-Oct-25 Ipca Laboratories Ltd - Board Meeting Intimation for Standalone And Consolidated Unaudited Financial Results For The 2Nd..
17-Oct-25 Ipca Laboratories Ltd - Board Meeting Outcome for Outcome Of Board Meeting
17-Oct-25 Ipca Laboratories Ltd - Slump Sale Of Companys Apis And Drug Intermediates Manufacturing Unit Situated At Ankleshwar
17-Oct-25 Ipca Laboratories Ltd - Slump Sale Of Companys Apis And Drug Intermediates Manufacturing Unit Situated At Ankleshwar
<< < 1 2 3 4   > >>